APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Indoleamine 2,3 Dioxygenase 1

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Indoleamine 2,3 Dioxygenase 1 Market Analysis and Forecast 2026-2032

Report ID 174002450219 December 2025194 pages

Choose your research edition.

Industry ResearchIndoleamine 2,3 Dioxygenase 1 Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Indoleamine 2,3 Dioxygenase 1 Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Indoleamine 2,3 Dioxygenase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indoleamine 2,3 Dioxygenase 1 Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Indoleamine 2,3 Dioxygenase 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Indoleamine 2,3 Dioxygenase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Indoleamine 2,3 Dioxygenase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Indoleamine 2,3 Dioxygenase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Indoleamine 2,3 Dioxygenase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Indoleamine 2,3 Dioxygenase 1 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Indoleamine 2,3 Dioxygenase 1 include F. Hoffmann-La Roche Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Regen BioPharma Inc, Redx Pharma Plc, NewLink Genetics Corp, Netherlands Translational Research Center BV, Kyowa Hakko Kirin and IO Biotech ApS, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Indoleamine 2,3 Dioxygenase 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Indoleamine 2,3 Dioxygenase 1, also provides the sales of main regions and countries. Of the upcoming market potential for Indoleamine 2,3 Dioxygenase 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Indoleamine 2,3 Dioxygenase 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Indoleamine 2,3 Dioxygenase 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Indoleamine 2,3 Dioxygenase 1 sales, projected growth trends, production technology, application and end-user industry.

Indoleamine 2,3 Dioxygenase 1 Segment by Company

F. Hoffmann-La Roche Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Regen BioPharma Inc

Redx Pharma Plc

NewLink Genetics Corp

Netherlands Translational Research Center BV

Kyowa Hakko Kirin

IO Biotech ApS

Incyte Corp

Globavir Biosciences Inc

Genentech Inc

Ensemble Therapeutics Corp

BirchBioMed Inc

Indoleamine 2,3 Dioxygenase 1 Segment by Type

BMS-986205

Dcellvax

F-001287

Galanal

Epacadostat

Others

Indoleamine 2,3 Dioxygenase 1 Segment by Application

Gastric Cancer

Aolpecia

Glioma

Cervical Cancer

Others

Indoleamine 2,3 Dioxygenase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indoleamine 2,3 Dioxygenase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indoleamine 2,3 Dioxygenase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indoleamine 2,3 Dioxygenase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Indoleamine 2,3 Dioxygenase 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Indoleamine 2,3 Dioxygenase 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Indoleamine 2,3 Dioxygenase 1 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. BMS-986205 Major Manufacturers Table 3. Dcellvax Major Manufacturers Table 4. F-001287 Major Manufacturers Table 5. Galanal Major Manufacturers Table 6. Epacadostat Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Gastric Cancer Major Manufacturers Table 10. Aolpecia Major Manufacturers Table 11. Glioma Major Manufacturers Table 12. Cervical Cancer Major Manufacturers Table 13. Others Major Manufacturers Table 14. Indoleamine 2,3 Dioxygenase 1 Industry Trends Table 15. Indoleamine 2,3 Dioxygenase 1 Industry Drivers Table 16. Indoleamine 2,3 Dioxygenase 1 Industry Opportunities and Challenges Table 17. Indoleamine 2,3 Dioxygenase 1 Industry Restraints Table 18. Global Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2021-2026) Table 22. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2027-2032) Table 23. Global Indoleamine 2,3 Dioxygenase 1 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 24. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026) & (K Units) Table 25. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2027-2032) & (K Units) Table 26. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2021-2026) Table 27. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2027-2032) Table 28. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Manufacturers (2021-2026) Table 32. Global Indoleamine 2,3 Dioxygenase 1 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Indoleamine 2,3 Dioxygenase 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Indoleamine 2,3 Dioxygenase 1 Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers, Product Type & Application Table 36. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Indoleamine 2,3 Dioxygenase 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2021-2026) Table 43. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2027-2032) Table 44. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 45. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 46. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 47. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2021-2026) Table 48. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2027-2032) Table 49. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2026) & (US$/Unit) Table 50. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2027-2032) & (US$/Unit) Table 51. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2021-2026) Table 55. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2027-2032) Table 56. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 57. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 58. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 59. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2021-2026) Table 60. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2027-2032) Table 61. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2026) & (US$/Unit) Table 62. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2027-2032) & (US$/Unit) Table 63. F. Hoffmann-La Roche Ltd Company Information Table 64. F. Hoffmann-La Roche Ltd Business Overview Table 65. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 67. F. Hoffmann-La Roche Ltd Recent Development Table 68. Pfizer Inc Company Information Table 69. Pfizer Inc Business Overview Table 70. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 72. Pfizer Inc Recent Development Table 73. Bristol-Myers Squibb Company Company Information Table 74. Bristol-Myers Squibb Company Business Overview Table 75. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 77. Bristol-Myers Squibb Company Recent Development Table 78. Regen BioPharma Inc Company Information Table 79. Regen BioPharma Inc Business Overview Table 80. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 82. Regen BioPharma Inc Recent Development Table 83. Redx Pharma Plc Company Information Table 84. Redx Pharma Plc Business Overview Table 85. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 87. Redx Pharma Plc Recent Development Table 88. NewLink Genetics Corp Company Information Table 89. NewLink Genetics Corp Business Overview Table 90. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 92. NewLink Genetics Corp Recent Development Table 93. Netherlands Translational Research Center BV Company Information Table 94. Netherlands Translational Research Center BV Business Overview Table 95. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 97. Netherlands Translational Research Center BV Recent Development Table 98. Kyowa Hakko Kirin Company Information Table 99. Kyowa Hakko Kirin Business Overview Table 100. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 102. Kyowa Hakko Kirin Recent Development Table 103. IO Biotech ApS Company Information Table 104. IO Biotech ApS Business Overview Table 105. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 107. IO Biotech ApS Recent Development Table 108. Incyte Corp Company Information Table 109. Incyte Corp Business Overview Table 110. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 112. Incyte Corp Recent Development Table 113. Globavir Biosciences Inc Company Information Table 114. Globavir Biosciences Inc Business Overview Table 115. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 117. Globavir Biosciences Inc Recent Development Table 118. Genentech Inc Company Information Table 119. Genentech Inc Business Overview Table 120. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 122. Genentech Inc Recent Development Table 123. Ensemble Therapeutics Corp Company Information Table 124. Ensemble Therapeutics Corp Business Overview Table 125. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 127. Ensemble Therapeutics Corp Recent Development Table 128. BirchBioMed Inc Company Information Table 129. BirchBioMed Inc Business Overview Table 130. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio Table 132. BirchBioMed Inc Recent Development Table 133. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 136. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 137. North America Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 138. North America Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 139. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 142. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 143. North America Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 144. North America Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 145. North America Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 150. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 151. North America Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 152. North America Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 153. United States Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 154. Canada Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 155. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (US$ Million) Table 156. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (US$ Million) Table 157. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 158. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 159. Europe Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 160. Europe Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 161. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (US$ Million) Table 162. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (US$ Million) Table 163. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 164. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 165. Europe Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 166. Europe Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 168. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 169. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 170. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 171. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 172. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 173. Europe Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 174. Europe Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 175. Germany Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 176. France Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 177. U.K. Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 178. Italy Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 179. Netherlands Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 180. China Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (US$ Million) Table 181. China Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (US$ Million) Table 182. China Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 183. China Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 184. China Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 185. China Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 186. China Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (US$ Million) Table 187. China Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (US$ Million) Table 188. China Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 189. China Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 190. China Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 191. China Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 195. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 196. Asia Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 197. Asia Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 198. Asia Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 201. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 202. Asia Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 203. Asia Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 204. Asia Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 209. Asia Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 210. Asia Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 211. Asia Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Japan Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 213. South Korea Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 214. India Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 215. Australia Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 216. China Taiwan Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 218. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (US$ Million) Table 219. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2027-2032) & (US$ Million) Table 220. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Units) Table 221. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Type (2027-2032) & (K Units) Table 222. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2021-2026) & (US$/Unit) Table 223. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Price by Type (2027-2032) & (US$/Unit) Table 224. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Units) Table 227. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Application (2027-2032) & (K Units) Table 228. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2021-2026) & (US$/Unit) Table 229. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Price by Application (2027-2032) & (US$/Unit) Table 230. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 234. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Units) Table 235. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Country (2027-2032) & (K Units) Table 236. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2021-2026) & (US$/Unit) Table 237. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Brazil Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 239. Argentina Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 240. Chile Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 241. Colombia Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 242. Peru Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 244. Israel Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 245. UAE Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 246. Turkey Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 247. Iran Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 248. Egypt Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. Indoleamine 2,3 Dioxygenase 1 Distributors List Table 252. Indoleamine 2,3 Dioxygenase 1 Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. Indoleamine 2,3 Dioxygenase 1 Image Figure 2. Global Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indoleamine 2,3 Dioxygenase 1 Market Size Share 2021 VS 2025 VS 2032 Figure 4. BMS-986205 Image Figure 5. Dcellvax Image Figure 6. F-001287 Image Figure 7. Galanal Image Figure 8. Epacadostat Image Figure 9. Others Image Figure 10. Global Indoleamine 2,3 Dioxygenase 1 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Indoleamine 2,3 Dioxygenase 1 Market Size Share 2021 VS 2025 VS 2032 Figure 12. Gastric Cancer Image Figure 13. Aolpecia Image Figure 14. Glioma Image Figure 15. Cervical Cancer Image Figure 16. Others Image Figure 17. Global Indoleamine 2,3 Dioxygenase 1 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Indoleamine 2,3 Dioxygenase 1 Revenue (2021-2032) & (US$ Million) Figure 19. Global Indoleamine 2,3 Dioxygenase 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2021-2032) Figure 22. Global Indoleamine 2,3 Dioxygenase 1 Sales (2021-2032) & (K Units) Figure 23. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 24. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Indoleamine 2,3 Dioxygenase 1 Sales YoY (2021-2032) & (K Units) Figure 26. Europe Indoleamine 2,3 Dioxygenase 1 Sales YoY (2021-2032) & (K Units) Figure 27. China Indoleamine 2,3 Dioxygenase 1 Sales YoY (2021-2032) & (K Units) Figure 28. Asia (Excluding China) Indoleamine 2,3 Dioxygenase 1 Sales YoY (2021-2032) & (K Units) Figure 29. South America, Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Sales YoY (2021-2032) & (K Units) Figure 30. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2021-2032) Figure 36. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2021-2032) Figure 39. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2021-2032) Figure 42. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 43. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2021-2032) Figure 45. North America Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2021-2032) Figure 46. North America Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2021-2032) Figure 47. North America Indoleamine 2,3 Dioxygenase 1 Revenue Share by Application (2021-2032) Figure 48. North America Indoleamine 2,3 Dioxygenase 1 Sales Share by Application (2021-2032) Figure 49. North America Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country (2021-2032) Figure 50. North America Indoleamine 2,3 Dioxygenase 1 Sales Share by Country (2021-2032) Figure 51. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2021-2032) Figure 52. Europe Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2021-2032) Figure 53. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Share by Application (2021-2032) Figure 54. Europe Indoleamine 2,3 Dioxygenase 1 Sales Share by Application (2021-2032) Figure 55. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country (2021-2032) Figure 56. Europe Indoleamine 2,3 Dioxygenase 1 Sales Share by Country (2021-2032) Figure 57. China Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2021-2032) Figure 58. China Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2021-2032) Figure 59. China Indoleamine 2,3 Dioxygenase 1 Revenue Share by Application (2021-2032) Figure 60. China Indoleamine 2,3 Dioxygenase 1 Sales Share by Application (2021-2032) Figure 61. Asia Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2021-2032) Figure 62. Asia Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2021-2032) Figure 63. Asia Indoleamine 2,3 Dioxygenase 1 Revenue Share by Application (2021-2032) Figure 64. Asia Indoleamine 2,3 Dioxygenase 1 Sales Share by Application (2021-2032) Figure 65. Asia Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country (2021-2032) Figure 66. Asia Indoleamine 2,3 Dioxygenase 1 Sales Share by Country (2021-2032) Figure 67. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Share by Type (2021-2032) Figure 68. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Share by Type (2021-2032) Figure 69. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Share by Application (2021-2032) Figure 70. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Share by Application (2021-2032) Figure 71. SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Share by Country (2021-2032) Figure 72. SAMEA Indoleamine 2,3 Dioxygenase 1 Sales Share by Country (2021-2032) Figure 73. Indoleamine 2,3 Dioxygenase 1 Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Indoleamine 2,3 Dioxygenase 1 Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • BMS-986205
  • Dcellvax
  • F-001287
  • Galanal
  • Epacadostat
  • Others
Applications
  • Gastric Cancer
  • Aolpecia
  • Glioma
  • Cervical Cancer
  • Others
Companies covered
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Regen BioPharma Inc
  • Redx Pharma Plc
  • NewLink Genetics Corp
  • Netherlands Translational Research Center BV
  • Kyowa Hakko Kirin
  • IO Biotech ApS
  • Incyte Corp
  • Globavir Biosciences Inc
  • Genentech Inc
  • Ensemble Therapeutics Corp
  • BirchBioMed Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Indoleamine 2,3 Dioxygenase 1 Market by Type
  3. 1.2.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 BMS-986205
  5. 1.2.3 Dcellvax
  6. 1.2.4 F-001287
  7. 1.2.5 Galanal
  8. 1.2.6 Epacadostat
  9. 1.2.7 Others
  10. 1.3 Indoleamine 2,3 Dioxygenase 1 Market by Application
  11. 1.3.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Gastric Cancer
  13. 1.3.3 Aolpecia
  14. 1.3.4 Glioma
  15. 1.3.5 Cervical Cancer
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Indoleamine 2,3 Dioxygenase 1 Market Dynamics
  1. 2.1 Indoleamine 2,3 Dioxygenase 1 Industry Trends
  2. 2.2 Indoleamine 2,3 Dioxygenase 1 Industry Drivers
  3. 2.3 Indoleamine 2,3 Dioxygenase 1 Industry Opportunities and Challenges
  4. 2.4 Indoleamine 2,3 Dioxygenase 1 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region
  3. 3.2.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2021-2026)
  5. 3.2.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2027-2032)
  6. 3.2.4 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region
  9. 3.4.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026)
  11. 3.4.3 Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2027-2032)
  12. 3.4.4 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturers
  2. 4.1.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturers
  6. 4.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Indoleamine 2,3 Dioxygenase 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Indoleamine 2,3 Dioxygenase 1 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers, Product Type & Application
  13. 4.7 Global Indoleamine 2,3 Dioxygenase 1 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Indoleamine 2,3 Dioxygenase 1 Market CR5 and HHI
  16. 4.8.2 2025 Indoleamine 2,3 Dioxygenase 1 Tier 1, Tier 2, and Tier 3
5 Indoleamine 2,3 Dioxygenase 1 Market by Type
  1. 5.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type
  2. 5.1.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Type
  6. 5.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Type
6 Indoleamine 2,3 Dioxygenase 1 Market by Application
  1. 6.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application
  2. 6.1.1 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Application
  6. 6.2.1 Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Application
7 Company Profiles
  1. 7.1 F. Hoffmann-La Roche Ltd
  2. 7.1.1 F. Hoffmann-La Roche Ltd Company Information
  3. 7.1.2 F. Hoffmann-La Roche Ltd Business Overview
  4. 7.1.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  6. 7.1.5 F. Hoffmann-La Roche Ltd Recent Developments
  7. 7.2 Pfizer Inc
  8. 7.2.1 Pfizer Inc Company Information
  9. 7.2.2 Pfizer Inc Business Overview
  10. 7.2.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  12. 7.2.5 Pfizer Inc Recent Developments
  13. 7.3 Bristol-Myers Squibb Company
  14. 7.3.1 Bristol-Myers Squibb Company Company Information
  15. 7.3.2 Bristol-Myers Squibb Company Business Overview
  16. 7.3.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 7.4 Regen BioPharma Inc
  20. 7.4.1 Regen BioPharma Inc Company Information
  21. 7.4.2 Regen BioPharma Inc Business Overview
  22. 7.4.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  24. 7.4.5 Regen BioPharma Inc Recent Developments
  25. 7.5 Redx Pharma Plc
  26. 7.5.1 Redx Pharma Plc Company Information
  27. 7.5.2 Redx Pharma Plc Business Overview
  28. 7.5.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  30. 7.5.5 Redx Pharma Plc Recent Developments
  31. 7.6 NewLink Genetics Corp
  32. 7.6.1 NewLink Genetics Corp Company Information
  33. 7.6.2 NewLink Genetics Corp Business Overview
  34. 7.6.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  36. 7.6.5 NewLink Genetics Corp Recent Developments
  37. 7.7 Netherlands Translational Research Center BV
  38. 7.7.1 Netherlands Translational Research Center BV Company Information
  39. 7.7.2 Netherlands Translational Research Center BV Business Overview
  40. 7.7.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  42. 7.7.5 Netherlands Translational Research Center BV Recent Developments
  43. 7.8 Kyowa Hakko Kirin
  44. 7.8.1 Kyowa Hakko Kirin Company Information
  45. 7.8.2 Kyowa Hakko Kirin Business Overview
  46. 7.8.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  48. 7.8.5 Kyowa Hakko Kirin Recent Developments
  49. 7.9 IO Biotech ApS
  50. 7.9.1 IO Biotech ApS Company Information
  51. 7.9.2 IO Biotech ApS Business Overview
  52. 7.9.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  54. 7.9.5 IO Biotech ApS Recent Developments
  55. 7.10 Incyte Corp
  56. 7.10.1 Incyte Corp Company Information
  57. 7.10.2 Incyte Corp Business Overview
  58. 7.10.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  60. 7.10.5 Incyte Corp Recent Developments
  61. 7.11 Globavir Biosciences Inc
  62. 7.11.1 Globavir Biosciences Inc Company Information
  63. 7.11.2 Globavir Biosciences Inc Business Overview
  64. 7.11.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  66. 7.11.5 Globavir Biosciences Inc Recent Developments
  67. 7.12 Genentech Inc
  68. 7.12.1 Genentech Inc Company Information
  69. 7.12.2 Genentech Inc Business Overview
  70. 7.12.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  72. 7.12.5 Genentech Inc Recent Developments
  73. 7.13 Ensemble Therapeutics Corp
  74. 7.13.1 Ensemble Therapeutics Corp Company Information
  75. 7.13.2 Ensemble Therapeutics Corp Business Overview
  76. 7.13.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  78. 7.13.5 Ensemble Therapeutics Corp Recent Developments
  79. 7.14 BirchBioMed Inc
  80. 7.14.1 BirchBioMed Inc Company Information
  81. 7.14.2 BirchBioMed Inc Business Overview
  82. 7.14.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product Portfolio
  84. 7.14.5 BirchBioMed Inc Recent Developments
8 North America
  1. 8.1 North America Indoleamine 2,3 Dioxygenase 1 Market Size by Type
  2. 8.1.1 North America Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032)
  3. 8.1.2 North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032)
  4. 8.1.3 North America Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2032)
  5. 8.2 North America Indoleamine 2,3 Dioxygenase 1 Market Size by Application
  6. 8.2.1 North America Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032)
  7. 8.2.2 North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032)
  8. 8.2.3 North America Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2032)
  9. 8.3 North America Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  10. 8.3.1 North America Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Indoleamine 2,3 Dioxygenase 1 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Type
  2. 9.1.1 Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032)
  4. 9.1.3 Europe Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2032)
  5. 9.2 Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Application
  6. 9.2.1 Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032)
  8. 9.2.3 Europe Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2032)
  9. 9.3 Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  10. 9.3.1 Europe Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Indoleamine 2,3 Dioxygenase 1 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Indoleamine 2,3 Dioxygenase 1 Market Size by Type
  2. 10.1.1 China Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032)
  3. 10.1.2 China Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032)
  4. 10.1.3 China Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2032)
  5. 10.2 China Indoleamine 2,3 Dioxygenase 1 Market Size by Application
  6. 10.2.1 China Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032)
  7. 10.2.2 China Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032)
  8. 10.2.3 China Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Indoleamine 2,3 Dioxygenase 1 Market Size by Type
  2. 11.1.1 Asia Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032)
  4. 11.1.3 Asia Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2032)
  5. 11.2 Asia Indoleamine 2,3 Dioxygenase 1 Market Size by Application
  6. 11.2.1 Asia Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032)
  8. 11.2.3 Asia Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2032)
  9. 11.3 Asia Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  10. 11.3.1 Asia Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Indoleamine 2,3 Dioxygenase 1 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Indoleamine 2,3 Dioxygenase 1 Market Size by Type
  2. 12.1.1 SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2032)
  5. 12.2 SAMEA Indoleamine 2,3 Dioxygenase 1 Market Size by Application
  6. 12.2.1 SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2032)
  9. 12.3 SAMEA Indoleamine 2,3 Dioxygenase 1 Market Size by Country
  10. 12.3.1 SAMEA Indoleamine 2,3 Dioxygenase 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Indoleamine 2,3 Dioxygenase 1 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Indoleamine 2,3 Dioxygenase 1 Value Chain Analysis
  2. 13.1.1 Indoleamine 2,3 Dioxygenase 1 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Indoleamine 2,3 Dioxygenase 1 Production Mode & Process
  6. 13.2 Indoleamine 2,3 Dioxygenase 1 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Indoleamine 2,3 Dioxygenase 1 Distributors
  9. 13.2.3 Indoleamine 2,3 Dioxygenase 1 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst